Search research articles
Contact Us
Filters
Showing results (1-10 of 107) with videos related to
Page
of 11
Sort By:
British Journal of Pharmacology
|
November 14, 2002
An assay to evaluate the long term effects of inflammatory mediators on airway smooth muscle: evidence that TNF(alpha)up-regulates 5-HT(2A) mediated contraction
Simon R Johnson
Thorax
|
January 16, 2016
Untangling the protease web in COPD: metalloproteinases in the silent zone
Simon R Johnson
Respiratory Medicine
|
May 11, 2010
The ERS guidelines for LAM: trying a rationale approach to a rare disease
Simon R Johnson
Clinical Medicine (London, England)
|
November 10, 2007
Management of rare diseases in respiratory medicine
Simon R Johnson
Thorax
|
August 1, 2019
Cross-sectional study of reversible airway obstruction in LAM: better evidence is needed for bronchodilator and inhaled steroid use
Jan Johnson, Simon R Johnson
American Journal of Respiratory and Critical Care Medicine
|
January 8, 2024
Lymphangioleiomyomatosis: No Longer Ultra-rare
Nishant Gupta, Simon R Johnson
Thorax
|
November 6, 2025
Prevalence and assessment of exercise-induced desaturation in lymphangioleiomyomatosis
Jan Johnson, Simon R Johnson
Thorax
|
May 17, 2020
Pneumothorax and the biology of Birt-Hogg-Dubé syndrome
Stefan J Marciniak, Simon R Johnson
Seminars in Respiratory and Critical Care Medicine
|
August 10, 2005
Lymphangioleiomyomatosis
Simon R Johnson, Anne E Tattersfield
Rheumatology (Oxford, England)
|
November 26, 2011
Interstitial lung disease following certolizumab pegol
Fiona Pearce, Simon R Johnson, Philip Courtney
Page
of 11
Search research articles
Search
Showing results (1-10 of 107) with videos related to
Sort By:
Page
of 11
British Journal of Pharmacology
|
November 14, 2002
An assay to evaluate the long term effects of inflammatory mediators on airway smooth muscle: evidence that TNF(alpha)up-regulates 5-HT(2A) mediated contraction
Simon R Johnson
Thorax
|
January 16, 2016
Untangling the protease web in COPD: metalloproteinases in the silent zone
Simon R Johnson
Respiratory Medicine
|
May 11, 2010
The ERS guidelines for LAM: trying a rationale approach to a rare disease
Simon R Johnson
Clinical Medicine (London, England)
|
November 10, 2007
Management of rare diseases in respiratory medicine
Simon R Johnson
Thorax
|
August 1, 2019
Cross-sectional study of reversible airway obstruction in LAM: better evidence is needed for bronchodilator and inhaled steroid use
Jan Johnson, Simon R Johnson
American Journal of Respiratory and Critical Care Medicine
|
January 8, 2024
Lymphangioleiomyomatosis: No Longer Ultra-rare
Nishant Gupta, Simon R Johnson
Thorax
|
November 6, 2025
Prevalence and assessment of exercise-induced desaturation in lymphangioleiomyomatosis
Jan Johnson, Simon R Johnson
Thorax
|
May 17, 2020
Pneumothorax and the biology of Birt-Hogg-Dubé syndrome
Stefan J Marciniak, Simon R Johnson
Seminars in Respiratory and Critical Care Medicine
|
August 10, 2005
Lymphangioleiomyomatosis
Simon R Johnson, Anne E Tattersfield
Rheumatology (Oxford, England)
|
November 26, 2011
Interstitial lung disease following certolizumab pegol
Fiona Pearce, Simon R Johnson, Philip Courtney
Page
of 11